Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

BACKGROUND: There is no consensus strategy for mineralocorticoid (MC) therapy titration in patients with primary adrenal insufficiency (PAI). We aim to measure serum fludrocortisone (sFC) and urine fludrocortisone (uFC) levels and to determine their utility, alongside clinical/biochemical variables...

Descripción completa

Detalles Bibliográficos
Autores principales: Pofi, Riccardo, Bonaventura, Ilaria, Duffy, Joanne, Maunsell, Zoe, Shine, Brian, Isidori, Andrea M, Tomlinson, Jeremy W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448575/
https://www.ncbi.nlm.nih.gov/pubmed/37410094
http://dx.doi.org/10.1530/EC-23-0059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448575/
https://www.ncbi.nlm.nih.gov/pubmed/37410094
http://dx.doi.org/10.1530/EC-23-0059

Ejemplares similares